CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 133 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2016. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $97,449,000 | +10.7% | 861,623 | -2.0% | 0.28% | +13.3% |
| Q1 2017 | $87,991,000 | -3.9% | 878,769 | +3.2% | 0.25% | -7.5% |
| Q4 2016 | $91,530,000 | +4.3% | 851,276 | +20.8% | 0.27% | +1.9% |
| Q3 2016 | $87,715,000 | +206.6% | 704,650 | +161.9% | 0.26% | +189.0% |
| Q2 2016 | $28,607,000 | +47.5% | 269,069 | +58.8% | 0.09% | +51.7% |
| Q1 2016 | $19,396,000 | -67.7% | 169,426 | -59.8% | 0.06% | -67.2% |
| Q4 2015 | $60,050,000 | +25.5% | 421,523 | -20.9% | 0.18% | +10.2% |
| Q3 2015 | $47,855,000 | -8.1% | 532,786 | +17.8% | 0.17% | 0.0% |
| Q2 2015 | $52,100,000 | +51.5% | 452,414 | +25.7% | 0.17% | +49.5% |
| Q1 2015 | $34,380,000 | +109.8% | 359,964 | +47.7% | 0.11% | +94.7% |
| Q4 2014 | $16,384,000 | +33.4% | 243,700 | +7.1% | 0.06% | +21.3% |
| Q3 2014 | $12,278,000 | +22.3% | 227,546 | +0.8% | 0.05% | +23.7% |
| Q2 2014 | $10,042,000 | – | 225,808 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
| RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
| Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
| OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
| Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
| Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
| Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
| Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
| Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |